Natalia Rodon1, Olga Diaz1, Montse Verdu1,2, Yessica No Garbarino1 and Xavier Puig1,2,3.
1BIOPAT. Biopatologia Molecular SL. Grup Assistència. Barcelona, Spain. 2HISTOPAT SL. Barcelona, Spain. 3Hospital de Barcelona, Grup Assistència. Barcelona, Spain.
Background and objectives
The results of DNA and RNA molecular profiles obtained from non-small cell lung cancer (NSCLC) and colorectal patients (CRC) since the implementation of a Next Generation Sequencing (NGS) panel in a diagnostic laboratory setting were analyzed. A review of the detected mutations in its clinicopathological context was performed and […]